Board of Directors

Chairman
Sue Siegel — Mohr Davidow

Ms. Siegel leads investments in companies focused on personalized medicine, enabling platform technologies for biomedical research, and innovative healthcare businesses with disruptive business models. Prior to joining Mohr Davidow, she was President and Director of Affymetrix, Inc., a company that pioneered GeneChip® technology, which helped accelerate the advent of personalized medicine in modern medicine. Ms. Siegel serves on the Board of Directors of Pacific Biosciences, Navigenics, Corventis, RainDance Technologies and On-Q-ity. She serves on the Presidents’ Circle of the National Academies, is an advisor to the Institute of Medicine, chairs the External Relations Committee of The Gladstone Institutes, and is a Henry Crown Fellow of the Aspen Institute. For more on Ms. Siegel, please click here.

Brook Byers — Kleiner Perkins Caufield & Byers (KPCB)

Mr. Byers has been a venture capital investor since 1972. He has been closely involved with more than 50 new technology-based ventures, over half of which have already become public companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 110 life sciences companies which have developed hundreds of products to treat major underserved medical needs for millions of patients. Mr. Byers is currently on the Board of Directors of 10 companies, most recently joining CardioDX, Genomic Health, Five Prime Therapeutics, OptiMedica®, Pacific Biosciences, Tethys and XDx. For more on Mr. Byers, please
click here.

William Hagstrom — President and Chief Executive Officer, Crescendo Bioscience

Mr. Hagstrom has over 25 years of leadership experience in the healthcare industry. Prior to joining Crescendo Bioscience, he was President of Alpha BioPartners, a strategic consulting firm for early-stage biotechnology companies. While at Alpha BioPartners, Mr. Hagstrom co-founded Altheus Therapeutics and Biolytx Pharmaceuticals. Previously, he served as President and CEO of UroCor, a specialty diagnostic services company focused on urological cancers, which he built from start-up through market launch, product expansion and penetration of over 35% of the U.S. urology market. Mr. Hagstrom has also held a variety of management positions in large, multinational healthcare companies including Becton, Dickinson and Company, American Hospital Supply and Baxter International.

Lawrence B. Leisure — Managing Partner, AccelusHealth Partners, LLC

Mr. Leisure is the Managing Partner at AccelusHealth Partners, LLC which provides advisory and consulting services to managed care and life sciences companies. Prior to founding AccelusHealth Partners he had a thirty year career in healthcare, serving in a number of senior consulting and industry roles at UnitedHealth Group, Kaiser Permanente, Accenture, Price Waterhouse and Towers Perrin. He currently sits on the boards of Crescendo Bioscience, Jiff, Seriosity and Tethys Bioscience as well as Navigenics and Redbrick Health where he is a board observer.

Jack L. Oliver III — Senior Advisor, Barclays and Senior Advisor, Bryan Cave LLP

Mr. Oliver is a Senior Advisor to Barclays, providing senior relationship management for top clients across investment banking, capital markets, and private wealth management. Additionally, he is a Senior Advisor of Bryan Cave LLP, an international law firm. Mr. Oliver served as National Finance Vice-Chairman for Bush-Cheney 04 and Victory 2004, managing the campaign’s $240 million national finance plan. Prior to that, Mr. Oliver was Deputy Chairman of the Republican National Committee. Mr. Oliver also works closely with the non-profit sector, having served for two years as Co-Chairman of the ONE Campaign, an organization to raise public awareness about global poverty and disease in developing countries, among other initiatives. In addition to Crescendo, Mr. Oliver is on the Board of Directors for E-Health Corporation and Innovus, Inc. For more on Mr. Oliver, please click here.

George M. Rehm — Managing Partner, aeris CAPITAL AG

George M. Rehm is a Managing Partner of aeris CAPITAL AG in Switzerland and has over twenty five years experience as a lawyer and executive in international licensing, technology transfer, investment and privatization transactions, involving the US, Europe and Asia, prior to commencing his current career in private equity. Currently, he holds board seats in numerous portfolio companies. Mr. Rehm remains of counsel to the Munich, Heidelberg and Berlin law firm of Weitnauer Partners. He received his BSFS from Georgetown University, and a JD from the University of California, Hastings College of Law.

Ralph Snyderman, MD — Founder and Chairman, Proventys™, Inc.

Dr. Snyderman is Chancellor Emeritus, Duke University and a James B. Duke Professor of Medicine at Duke University. He served as Duke’s Chancellor for Health Affairs and Dean of the School of Medicine from 1989 to July 2004. Dr. Snyderman oversaw the development of the Duke University Health System, one of the nation’s most successful integrated academic health systems, and served as its first President and Chief Executive Officer. Dr. Snyderman is also the founder and chairman of Proventys, a healthcare technology company that develops risk assessment and clinical decision support tools to support personalized medicine and was a venture partner at New Enterprise Associates, based in Menlo Park, California. Dr. Snyderman serves on the Board of Directors of Liquidia Technologies, National Health Museum, Targacept, Inc., Trevena, Inc., XDx, Inc., and the Washington College Board of Visitors and Governors. For more on Dr. Snyderman, please click here.